Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUPRIYA LIFESCIENCE vs LYKA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUPRIYA LIFESCIENCE LYKA LABS SUPRIYA LIFESCIENCE /
LYKA LABS
 
P/E (TTM) x 41.0 163.6 25.0% View Chart
P/BV x 7.9 8.7 91.4% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 SUPRIYA LIFESCIENCE    LYKA LABS
EQUITY SHARE DATA
    SUPRIYA LIFESCIENCE
Mar-24
LYKA LABS
Mar-24
SUPRIYA LIFESCIENCE /
LYKA LABS
5-Yr Chart
Click to enlarge
High Rs394144 274.4%   
Low Rs19189 214.3%   
Sales per share (Unadj.) Rs61.433.6 182.6%  
Earnings per share (Unadj.) Rs14.8-0.8 -1,868.5%  
Cash flow per share (Unadj.) Rs16.83.1 544.9%  
Dividends per share (Unadj.) Rs0.800-  
Avg Dividend yield %0.30-  
Book value per share (Unadj.) Rs101.317.9 567.4%  
Shares outstanding (eoy) m80.4833.09 243.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.83.5 137.7%   
Avg P/E ratio x19.7-146.8 -13.4%  
P/CF ratio (eoy) x17.437.8 46.1%  
Price / Book Value ratio x2.96.5 44.3%  
Dividend payout %5.40-   
Avg Mkt Cap Rs m23,5173,847 611.4%   
No. of employees `000NANA-   
Total wages/salary Rs m676268 252.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4,9381,112 444.1%  
Other income Rs m11015 753.0%   
Total revenues Rs m5,0471,126 448.1%   
Gross profit Rs m1,757153 1,148.0%  
Depreciation Rs m158128 123.5%   
Interest Rs m5149 105.3%   
Profit before tax Rs m1,657-9 -17,739.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m46617 2,760.9%   
Profit after tax Rs m1,191-26 -4,544.6%  
Gross profit margin %35.613.8 258.5%  
Effective tax rate %28.1-180.6 -15.6%   
Net profit margin %24.1-2.4 -1,023.6%  
BALANCE SHEET DATA
Current assets Rs m4,005507 790.7%   
Current liabilities Rs m796376 211.4%   
Net working cap to sales %65.011.7 555.4%  
Current ratio x5.01.3 374.0%  
Inventory Days Days4883 57.3%  
Debtors Days Days83886 9.3%  
Net fixed assets Rs m5,2341,061 493.5%   
Share capital Rs m161331 48.6%   
"Free" reserves Rs m7,993260 3,074.5%   
Net worth Rs m8,154591 1,379.9%   
Long term debt Rs m0429 0.0%   
Total assets Rs m9,2391,567 589.5%  
Interest coverage x33.20.8 4,101.1%   
Debt to equity ratio x00.7 0.0%  
Sales to assets ratio x0.50.7 75.3%   
Return on assets %13.41.4 928.4%  
Return on equity %14.6-4.4 -329.4%  
Return on capital %21.03.9 540.0%  
Exports to sales %91.10-   
Imports to sales %16.10-   
Exports (fob) Rs m4,498NA-   
Imports (cif) Rs m793NA-   
Fx inflow Rs m4,4980-   
Fx outflow Rs m7930-   
Net fx Rs m3,7050-   
CASH FLOW
From Operations Rs m1,13318 6,390.7%  
From Investments Rs m-1,736-95 1,829.4%  
From Financial Activity Rs m-22420 -1,144.9%  
Net Cashflow Rs m-826-58 1,434.0%  

Share Holding

Indian Promoters % 68.3 58.1 117.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.5 0.8 1,400.0%  
FIIs % 6.0 0.2 4,020.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 41.9 75.7%  
Shareholders   85,328 28,943 294.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUPRIYA LIFESCIENCE With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on SUPRIYA LIFESCIENCE vs LYKA LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SUPRIYA LIFESCIENCE vs LYKA LABS Share Price Performance

Period SUPRIYA LIFESCIENCE LYKA LABS S&P BSE HEALTHCARE
1-Day 13.87% 1.81% 1.23%
1-Month 55.24% 4.75% -0.24%
1-Year 219.19% 9.72% 43.62%
3-Year CAGR 27.12% 5.24% 20.35%
5-Year CAGR 15.48% 53.27% 26.24%

* Compound Annual Growth Rate

Here are more details on the SUPRIYA LIFESCIENCE share price and the LYKA LABS share price.

Moving on to shareholding structures...

The promoters of SUPRIYA LIFESCIENCE hold a 68.3% stake in the company. In case of LYKA LABS the stake stands at 58.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SUPRIYA LIFESCIENCE and the shareholding pattern of LYKA LABS.

Finally, a word on dividends...

In the most recent financial year, SUPRIYA LIFESCIENCE paid a dividend of Rs 0.8 per share. This amounted to a Dividend Payout ratio of 5.4%.

LYKA LABS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of SUPRIYA LIFESCIENCE , and the dividend history of LYKA LABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.